You have 1 action to finish to complete your account. Craft your experience by picking your interest on the Personalisation Page
Gastroenterology

Cumulative Exposure to Corticosteroids in Type 2 Inflammatory Diseases

Dr. Evan Dellon highlights potential risks with cumulative use of steroids for treatment of various coexisting type 2 inflammatory diseases.

Evan  Dellon
MD, MPH
Evan Dellon

Learning objectives

  • Recognize the potential for complications with cumulative exposure to steroid treatment of coexisting diseases with underlying type 2 inflammation

Description

Join global expert Evan Dellon, MD, MPH, as he highlights different ways that corticosteroids may be taken by a patient for various type 2 inflammatory diseases, and discusses the cumulative risk for steroid complications.

MAT-US-2105960 v3.0 P - Exp. Date 06/30/2025

About this expert

Gastroenterology

Evan Dellon

MD, MPH

Professor of Medicine and Adjunct Professor of Epidemiology | University of North Carolina School of Medicine, Chapel Hill, United States

See author’s profile
Evan  Dellon

Related resources